Matrix Capital Management Company, LP's Net Worth
$343 Million
Who is Matrix Capital Management Company, LP?
Matrix Capital Management Company, LP has an estimated net worth of $343 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, Aura Biosciences, Inc., and Zentalis Pharmaceuticals, Inc..
SEC CIK
Matrix Capital Management Company, LP's CIK is 0001410830
Past Insider Trading and Trends
2019 was Matrix Capital Management Company, LP's most active year for acquiring shares with 4 total transactions. Matrix Capital Management Company, LP's most active month to acquire stocks was the month of June. 2021 was Matrix Capital Management Company, LP's most active year for disposing of shares, totalling 10 transactions. Matrix Capital Management Company, LP's most active month to dispose stocks was the month of February. 2023 saw Matrix Capital Management Company, LP paying a total of $121,901,600.00 for 6,320,000 shares, this is the most they've acquired in one year. In 2020 Matrix Capital Management Company, LP cashed out on 4,217,101 shares for a total of $138,753,176.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adaptive Biotechnologies Corp (ADPT) Snapshot price: $3.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.15% | -806.00K |
$39.99 | -$32,228,826.74 | 12.31M |
Mar 8 - Mar 10
| |||
Form 4
| -13.23% | -2.00M |
$40.00 | -$80,000,000.00 | 13.12M |
Jul 20
| |||
Form 4
| -12.79% | -2.22M |
$26.50 | -$58,753,176.50 | 15.12M |
Jan 24
| |||
Form 4
|
∞
| 17.33M |
—
|
—
| 17.33M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aura Biosciences, Inc. (AURA) Snapshot price: $8.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.09% | 1.56M |
$9.00 | $14,040,000.00 | 6.92M |
Nov 9
| |||
Form 4
| +30.39% | 1.25M |
$12.00 | $15,000,000.00 | 5.36M |
Dec 5
| |||
Form 4
| +176.68% | 4.11M |
$14.00 | $24,990,000.00 | 6.44M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zentalis Pharmaceuticals, Inc. (ZNTL) Snapshot price: $11.36
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +51.74% | 4.76M |
$22.66 | $107,861,600.00 | 13.96M |
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||